These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19281222)

  • 41. Crystal structure of the IMP-1 metallo beta-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor.
    Concha NO; Janson CA; Rowling P; Pearson S; Cheever CA; Clarke BP; Lewis C; Galleni M; Frère JM; Payne DJ; Bateson JH; Abdel-Meguid SS
    Biochemistry; 2000 Apr; 39(15):4288-98. PubMed ID: 10757977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-based approach for identification of novel phenylboronic acids as serine-β-lactamase inhibitors.
    Sgrignani J; De Luca F; Torosyan H; Docquier JD; Duan D; Novati B; Prati F; Colombo G; Grazioso G
    J Comput Aided Mol Des; 2016 Oct; 30(10):851-861. PubMed ID: 27632226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. beta-Lactamase binds to GroEL in a conformation highly protected against hydrogen/deuterium exchange.
    Gervasoni P; Staudenmann W; James P; Gehrig P; Plückthun A
    Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12189-94. PubMed ID: 8901555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contributions of aspartate 49 and phenylalanine 142 residues of a tight binding inhibitory protein of beta-lactamases.
    Petrosino J; Rudgers G; Gilbert H; Palzkill T
    J Biol Chem; 1999 Jan; 274(4):2394-400. PubMed ID: 9891008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamase.
    Powers RA; Blázquez J; Weston GS; Morosini MI; Baquero F; Shoichet BK
    Protein Sci; 1999 Nov; 8(11):2330-7. PubMed ID: 10595535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of class A beta-lactamases by carbapenems: crystallographic observation of two conformations of meropenem in SHV-1.
    Nukaga M; Bethel CR; Thomson JM; Hujer AM; Distler A; Anderson VE; Knox JR; Bonomo RA
    J Am Chem Soc; 2008 Sep; 130(38):12656-62. PubMed ID: 18761444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serendipitous discovery of aryl boronic acids as β-lactamase inhibitors.
    Yang SW; Pan J; Root Y; Scapin G; Xiao L; Su J
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126795. PubMed ID: 31759850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of the OXA-48 Carbapenemase Family by Use of Tryptic Peptides and Liquid Chromatography-Tandem Mass Spectrometry.
    Strich JR; Wang H; Cissé OH; Youn JH; Drake SK; Chen Y; Rosenberg AZ; Gucek M; McGann PT; Dekker JP; Suffredini AF
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30814261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activity of avibactam against Enterobacter cloacae producing an extended-spectrum class C β-lactamase enzyme.
    Lahiri SD; Giacobbe RA; Johnstone MR; Alm RA
    J Antimicrob Chemother; 2014 Nov; 69(11):2942-6. PubMed ID: 24986496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.
    Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538183
    [No Abstract]   [Full Text] [Related]  

  • 52. Structural basis for the extended substrate spectrum of AmpC BER and structure-guided discovery of the inhibition activity of citrate against the class C β-lactamases AmpC BER and CMY-10.
    Na JH; Cha SS
    Acta Crystallogr D Struct Biol; 2016 Aug; 72(Pt 8):976-85. PubMed ID: 27487828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thermodynamic evaluation of a covalently bonded transition state analogue inhibitor: inhibition of beta-lactamases by phosphonates.
    Nagarajan R; Pratt RF
    Biochemistry; 2004 Aug; 43(30):9664-73. PubMed ID: 15274621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and Validation Novel of VIM-2 Metallo-β-lactamase Tripeptide Inhibitors.
    Xiao J; Fang M; Shi Y; Chen H; Shen B; Chen J; Lao X; Xu H; Zheng H
    Mol Inform; 2015 Aug; 34(8):559-67. PubMed ID: 27490501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergy and antagonism of promiscuous inhibition in multiple-compound mixtures.
    Feng BY; Shoichet BK
    J Med Chem; 2006 Apr; 49(7):2151-4. PubMed ID: 16570910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of the SHV-1 beta-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam.
    Kuzin AP; Nukaga M; Nukaga Y; Hujer A; Bonomo RA; Knox JR
    Biochemistry; 2001 Feb; 40(6):1861-6. PubMed ID: 11327849
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.
    Totir MA; Padayatti PS; Helfand MS; Carey MP; Bonomo RA; Carey PR; van den Akker F
    Biochemistry; 2006 Oct; 45(39):11895-904. PubMed ID: 17002290
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A fluorescein-labeled AmpC β-lactamase allows rapid characterization of β-lactamase inhibitors by real-time fluorescence monitoring of the β-lactamase-inhibitor interactions.
    Tsang MW; Chan PH; Liu SY; Wong KY; Leung YC
    Biotechnol J; 2016 Feb; 11(2):257-65. PubMed ID: 26250526
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A broad-spectrum peptide inhibitor of beta-lactamase identified using phage display and peptide arrays.
    Huang W; Beharry Z; Zhang Z; Palzkill T
    Protein Eng; 2003 Nov; 16(11):853-60. PubMed ID: 14631075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design of potent beta-lactamase inhibitors by phage display of beta-lactamase inhibitory protein.
    Huang W; Zhang Z; Palzkill T
    J Biol Chem; 2000 May; 275(20):14964-8. PubMed ID: 10748011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.